Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...

Biodesix (NYSE:BDSX) saw its stock jump 10% on Wednesday after announcing an expanded partnership with Bio-Rad Laboratories ...

B iodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro ...

The QuantaLife ddPCR System claims to be the world's most precise quantitative PCR system. It introduces the next generation of PCR by providing absolute quantification of targeted nucleic acid ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) ...

In the first study 1, clinicians in Wuhan, China observed that a subset of infected individuals who tested negative for COVID-19 using qPCR tested positive using ddPCR. The findings suggest that ddPCR ...

Investing.com -- Biodesix (NYSE:BDSX) stock rose 10% Wednesday after the diagnostics solutions company announced an expanded partnership agreement with Bio-Rad Laboratories to develop high complexity ...

Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using ...

Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...